Products Affected - Description

• • Mesnex solution for injection, Baxter, 100 mg/mL, 10 mL vial, 1 count, NDC 00338-1305-01
  • Mesna solution for injection, Baxter, 100 mg/mL, 10 mL vial, 1 count, NDC 10019-0953-01
  • Mesna solution for injection, Fresenius Kabi, 100 mg/mL, 10 mL vial, 1 count, NDC 63323-0733-11
  • Mesna solution for injection, Sagent, 100 mg/mL, 10 mL vial, 1 count, NDC 25021-0201-10
  • Mesna solution for injection, Sagent, 100 mg/mL, 10 mL vial, 10 count, NDC 25021-0201-11

Reason for the Shortage

• • Baxter has mesna injection on shortage due to increased demand. The 10 count presentations have been discontinued.
  • Fresenius Kabi did not provide a reason for the shortage.
  • Sagent did not provide a reason for the shortage.

Available Products

• • There is insufficient supply for usual ordering

• • Fresenius Kabi has mesna 100 mg/mL 10 mL vials in single count on back order and the company cannot estimate a release date.
  • Sagent has mesna 100 mg/mL 10 mL vials in 10 count on back order and the company cannot estimate a release date. There are short-dated single count packs available with an expiration date of May 2024.
  • Baxter has mesna 100 mg/mL 10 mL vials on allocation.
  • Baxter has Mesnex 100 mg/mL 10 mL vials on allocation.